MetaCap

Erasca Statistics

NASDAQ: ERASHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.61-0.61 (-4.29%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Erasca by the numbers

Erasca has a market capitalization of $4.78 billion based on 350.96M shares outstanding. With trailing EPS of $-0.97, Erasca is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.8% below its 50-day average and 11.2% below its 200-day average.

Average daily trading volume is 5.27M shares, or about $71.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ERAS valuation vs. peer median

ERAS compared with the median of 8 peer companies
MetricERASPeer medianDifference
Market cap$4.78B$4.74B+1%
Avg. volume5.27M1.44M+265%

Peer median across 8 companies: DNTH, PTCT, LQDA, COGT, TVTX, MANE, IONS, BLTE.

Valuation

Price and trading

Previous close
14.22
Open
13.13
Day range
13.13 – 14.31
52-week range
2.81 – 24.28
52-week change
+366.10%
Beta
—
Volume
11.07M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
4.78B
Forward Pe
-17.36
Eps
-0.97
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
24.28
Week52 Low
2.81
Avg Volume
5.27M
Shares Outstanding
350.96M
Ma50
14.77
Ma200
15.33
Earnings Date
Nov 12, 2026
Pct From52w High
-43.95%
Pct From52w Low
384.34%

Related